CorMedix
CRMD
35 hedge funds and large institutions have $1.56M invested in CorMedix in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 34 → 35 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.41% less ownership
Funds ownership: 2.53% → 2.12% (-0.41%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
63% less capital invested
Capital invested by funds: $4.26M → $1.56M (-$2.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $40K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$101K |
| 2 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$88K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$31.5K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$18.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$114K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$84K |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$43K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
CRMD Hedge Fund Activity: Q1 2018 in Review
35 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2018, worth a combined $1.56M — down 63% from $4.26M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CRMD positions and 7 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $101K. The largest seller was Virtu Financial, exiting entirely with an estimated $114K sold.
- 35 institutional investors held CorMedix (CRMD) as of Q1 2018, up from 34 in Q4 2017.
- Funds reported $1.56M of CorMedix stock for Q1 2018, down 63% quarter-over-quarter.
- 8 funds opened new CorMedix positions in Q1 2018 and 7 closed out, a net change of +1 holder.
- The largest CorMedix buyer in Q1 2018 was Citadel Advisors, an estimated $101K added.
- The largest CorMedix seller in Q1 2018 was Virtu Financial, an estimated $114K sold.
Based on aggregated 13F filings for Q1 2018.